TRIAL MASTER FILE - pmaconference.com · • Sessions on industrywide TMF initiatives, including the Exchange Mechanism and Framework for the Destruction of Paper • A drinks reception

Effect Inspection Readiness, Quality, and Streamlined Operations Using Technology and

Improved Internal and External Alliances

January 22–24, 2019

Hilton Orlando Lake Buena Vista

Orlando, FL

TRIAL MASTER FILE SUMMIT

8TH

28TH TRIAL MASTER FILE SUMMIT


8TH

TABLE OF CONTENTS

Advisory Board Members 2

Opening Letter 3

Hotel Information 3

Who Should Attend 4

Agenda-at-a-Glance 5

Sponsors and Partners 6

Conference Speakers 7

Preconference Training Day 9

Main Conference Day One

Morning Plenary Sessions 10

Afternoon Track Sessions 11

Main Conference Day Two

Morning Track Sessions 13

Afternoon Plenary Sessions 15

How to Register 16

TMF Series Calendar 17

THANK YOU TO OUR 8TH TMF SUMMIT ADVISORY BOARD

Wendy Beeby Director, Clinical Document Management and Inspection Readiness SHIRE

Grace Crawford VP Clinical Quality and Compliance MEDIMMUNE

Liz Farrell Senior Manager, Trial Master File BIOGEN

Joanne S. Malia Associate Director, Clinical Documentation Management REGENERON

Joy Mehlenbacher-Mohamed Manager, Clinical Support and Quality Documentation BOEHRINGER INGELHEIM

Curran Murphy Director, Clinical Operations DECIPHERA PHARMACEUTICALS

Karen Roy Chief Strategy Officer PHLEXGLOBAL

Bryan Souder Director, TMF Head MERCK

Jamie Toth Director and Head of TMF Operations DAIICHI SANKYO

Ivan Walrath Head of Audit and Inspection Quality PFIZER

Karen Whitson Assistant Director, Clinical Documentation Center ABBVIE

Alana Wriggins Head Site Management, North America, Acquisition Integration and Clinical Records Management ALLERGAN

8TH


3

Dear Colleague,Since the inception of the TMF Summit in 2012, ExL has been dedicated to educating leaders, administrators and other stakeholders in the global TMF community. We have also had a front-row seat to the evolution of TMF from a paper-based document process to electronic systems. Technological innovation, specialization of the workforce, and industrywide collegiality converted TMFs from their traditional role as a repository to becoming veritable assets. TMFs are being leveraged for quality control, streamlining process, improving inspection readiness, and reducing findings.

With the industry at the start of an innovation revolution, we have built an agenda focusing on inspection readiness, quality and streamlined operations using technology, metrics, and improved alliances.

We take pride in the fact that more than 250 attendees will participate to benefit from the event’s networking opportunities, sharing of ideas and dissemination of best practices and diversity of insights. This year we added to diversity of perspectives stakeholder by increasing participation of sites, CROs and internal stakeholders from other clinical function areas.

The 8th Trial Master File Summit will feature• A needs-driven program directed by an advisory board composed of 12 preeminent TMF leaders• Six tracks focusing on metrics, document management, CRO and site alliances, inspections, business/integration

and technology• Preconference training day, two seminars, and a dinner workshop• Diversity of perspectives among 55+ faculty members from the sponsor, site, CRO, regulatory, and vendor communities• Six panels, including one with representatives from sites panels• 40 sessions, including 10 select case studies• Five sessions on groundbreaking AI and other technological initiatives• Sessions on industrywide TMF initiatives, including the Exchange Mechanism and Framework for the Destruction of Paper• A drinks reception and a walking tour to extend networking to over 18+ hours

Join us for unique case studies, panels, seminars, workshops, and the best networking the industry has to offer.

Sincerely,

Brian L Anderson Scott Grossman Senior Conference Producer, Trial Master File Series Division Head, Conference Production

ExL Events, a division of Questex, LLC ExL Events, a division of Questex, LLC

1751 Hotel Plaza BlvdLake Buena Vista, FL 32830

To make reservations, please call 1-800-782-4414 and request the nego-tiated rate for ExL’s January Meetings. You may also make reservations online using the following weblink: https://goo.gl/1u7bYK. The group rate is available until January 3, 2019. Please book your room early, as rooms available at this rate are limited.

*ExL Events is not affiliated with Exhibition Housing Management (EHM)/Exhibitors Housing Services (EHS) or any third-party booking agencies, housing bureaus or travel companies. ExL Events is affiliated with event company Questex, LLC. In the event that an outside party contacts you for any type of hotel or travel arrangements, please disregard these solicitations and kindly email us at [email protected]. ExL has not authorized these companies to contact you and we do not verify the legitimacy of the services or rates offered. Please book your guest rooms through ExL’s reserved guest room block using the details provided.

Venue

HILTON ORLANDO LAKE BUENA VISTA

#1 TMF EVENTWORLDWIDE


Who Should AttendThis conference is designed for representatives from pharmaceutical, biotech, medical device and clinical research companies with responsibilities in the following areas:

d TMF and eTMF Management d Clinical Document/Data Management

d Clinical Trial Administration d Clinical Operations/Process d Regulatory Affairs/Operations d Trial, Document and Record Management

d Document and Record Specialist d Clinical Document Coordination

d Clinical Development/Study Management

d Quality Assurance/Control/Operations

d Competency Development

d Strategic Operations and Planning

d Quality Management

d Informatics

d Clinical IT

This conference is also of interest to d eTMF Service Providers d Data/Records Management d Clinical Research Organizations d Paper and Electronic Archiving d Solution Providers

2018 AUDIENCE BREAKDOWN

36% Biotech

8% Others

4% Medical Devices

38% Pharma

5% Research 14%

Administrator/Coordinator/Assistant

41% Manager/Lead

18% C-Level/President/

VP/Director

Industry Breakdown Seniority BreakdownCalifornia 17%Colorado 1%Connecticut 1%Delaware 1%Illinois 3%Indiana 4%Kansas 1%Maryland 5%Massachusetts 14%Michigan 1%

Nebraska 1%New Jersey 6%New York 2%North Carolina 11%Ohio 1%Pennsylvania 6%Texas 1%Virginia 2%Washington 3%

States Represented

9% CRO

27% Associate/Specialist

Canada 2%Germany 1%India 1%Poland 1%

Slovakia 1%Sweden 1%USA 79%

Countries Represented

36% Biotech

8%Others

4% Medical Devices

38% Pharma

5% Research 14%

Administrator/Coordinator/Assistant

41% Manager/Lead

18% C-Level/President/

VP/Director

Industry Breakdown Seniority BreakdownCalifornia 17%Colorado 1%Connecticut 1%Delaware 1%Illinois 3%Indiana 4%Kansas 1%Maryland 5%Massachusetts 14%Michigan 1%

Nebraska 1%New Jersey 6%New York 2%North Carolina 11%Ohio 1%Pennsylvania 6%Texas 1%Virginia 2%Washington 3%

States Represented

9%CRO

27% Associate/Specialist

Canada 2%Germany 1%India 1%Poland 1%

Slovakia 1%Sweden 1%USA 79%



Brazil

Canada

Denmark

France

Germany

India

Japan

Poland

Slovakia

South Korea

Sweden

Switzerland

UK

United States

Tuesday, January 22, 2019 | Preconference Training Day7:30 Registration Begins and Continental Breakfast

8:30-3:30 Seminar 1 Create a Process for TMF Documentation

Seminar 2 Define, Develop, Manage and Enhance Your TMF Team

4:00-7:30 Dinner Workshop SURVEYING EACH STUDY’S NEEDS TO ENSURE SUCCESSFUL SUPPORT BY THE TMF OPERATIONS TEAM

Wednesday, January 23, 2019 | Main Conference Day One8:00 Registration and Continental Breakfast9:00 Chairpersons’ Opening Remarks9:30 Use AI to Improve Efficiency in Filing, Indexing Documents, and Completeness and Accuracy of the TMF Content

10:15 Apply Machine Learning and Artificial Intelligence10:45 Collaborate Effectively to Transform Clinical Trials11:15 Networking Break11:45 Case Study: Improve Quality and Execute a Culture Change Through Assessing and Addressing TMF Stakeholder Input12:30 Maintain an Inspection-Ready TMF With a Comprehensive and Coherent Approach by Accounting for Variables in Your Quality Management System

1:00 Networking Luncheon

METRICS AND TOOLS DOCUMENT MANAGEMENT CROS/SITES 2:00 Case Study: Tailor Metrics to Particular Functional

Areas to Identify IssuesLearn About the Framework for the Destruction of Paper and Discuss Its Ramifications

Panel: Look at Proactive and Coping Measures for TMFs With Limited Resources at Start-Up

2:40 Transition Time2:45 Presentation by Wingspan Technologies Case Study: Use AI to Manage Documents Meet ICH E6(R2) Expectations of Regulators Through CRO

Oversight and Collaboration3:25 Networking Break3:30 Shift the Paradigm to Measure What Matters Ensure Seamless Audits by Making the Most of What

Your eTMF Offers Enhance Your CRO/Sponsor Relationship While Maintaining a Constant State of Inspection Readiness

4:10 Transition Time4:15 Case Study: Learn About AbbVie’s Risk-Based QC

ProcessCase Study: Plan and Execute Migrations of Disparate Types of TMFs

Case Study: Provide Inspection Support With Comprehensive Guidance, Instruction, Training and Support to CROs Using Their Own eTMF System

5:00 Networking Reception6:00 Day One Concludes

Thursday, January 24, 2019 | Main Conference Day Two8:15 Continental Breakfast Begins

INSPECTIONS BUSINESS/INTEGRATION eTMF/TECHNOLOGY

9:00 Track Chair’s Recap Day One Track Chair’s Recap Day One Track Chair’s Recap Day One 9:10 PANEL: Prepare for a TMF Inspection With

a Quality Management SystemCase Study: Steps to Build a RobustFunction QC Process to Ensure IR

Leverage Your eTMF Technology to Engage Stakeholders Through a Business – IT Approach

9:55 Transition Time10:00 Contend With Pain Points of Acquisition to

Passing InspectionCase Study: Business Embedment: Influence Corporate Strategy With C-Level Buy-In

Improve Interoperability Through Automation

10:45 Networking Break11:15 Case Study — E Pluribus Unum, Achieve SSOT Case Study: Align Technologies and Streamline

Processes to Support the Ability of Cross-Functions to Work With Vendors

Born to Be Contemporaneous: Road Mapping Your eTMF to Evolve Technology in Accord With Changing Passenger Need, Rules of the Road, and Road Conditions

12:00 Transition Time12:10 Work in Concert With Your CRO Partners to Prepare

for Inspection in Accordance With Trends Case Study: Hear a Journey to TMF Compliance — A CT Supply Chain Functional Perspective Through ThreeLenses (Quality, Business, and Cross-Functional Collaboration)

Panel: Explore the Impact, Prerequisites and Application of Emerging Technologies

12:45 Networking Luncheon 1:45 PANEL: The Future of eTMF: What Are the Key Change Enablers? 2:30 PANEL: Be Inspection-Ready by Effecting a Unified TMF by Collaborating With CROs

3:15 PANEL: Learn From Sites to Standardize Procedures, Provide Support and Develop Trainings 4:15 Chairpersons’ Closing Remarks5:00 Conference Concludes

5

Agenda-At-A-Glance


THANK YOU to Our Sponsors and Partners

Spread the word about your organization’s solutions and services to potential clients attending this event. Take advantage of the opportunity to exhibit, underwrite an educational session, host a networking event or distribute promotional items to attendees.

Dor Peled Business Development [email protected]

PARTNERS

SPONSORS

ASSOCIATION AND MEDIA PARTNER OPPORTUNITIES We work closely with potential partner organizations to create synergies that benefit both partners.

SPONSORSHIP AND EXHIBITION OPPORTUNITIES

Christina Allen, Senior TMF Specialist, TMF Operations, DAIICHI SANKYO

Jennifer Arters, eClinical Manager eTMF and Collaboration, CSL BEHRING

Evelin Baez, Clinical Document Management Specialist, BECTON DICKINSON

Wendy Beeby, Director, Clinical Document Management and Inspection Readiness, SHIRE

Andy Chu, Director, Regulatory Affairs - Regulatory Systems Strategy, BIOGEN

Kathie Clark, Vice President, Product Management, WINGSPAN TECHNOLOGY, AN IQVIA COMPANY

Grace Crawford, VP Clinical Quality and Compliance, MEDIMMUNE

Sonja Davis, QA Consultant, QA-Product Research and Development, ELI LILLY

Elias Dorfman, Clinical Quality Manager, MERCK

Martina Duevel, Systems Excellence Project Leader, BAYER

Mary Emanoli, Senior Director, Content Management and Authoring, PFIZER

Betsy Fallen, Special Topics Consultant, SAFE BIOPHARMA

Liz Farrell, Senior Manager, Trial Master File, BIOGEN

Paul Fenton, President and CEO, MONTRIUM

Karen Freid, Essential Document Specialist, MERCK

Patty Fulton, Quality Consultant, TMF, ELI LILLY

Amy Gunnett, Certified Clinical Research Coordinator, UNIVERSITY OF FLORIDA

Rebecca Halbur, Senior Manager, TMF Systems, BIOGEN

Nela Hayes, Senior Manager, Clinical Documentation, ABBVIE

Victoria Ho, Director Clinical Operations, GILEAD

Aryn Knight, Clinical Research Oversight Specialist; Assistant Administrative Director — Center for Clinical Research, TEXAS HEART INSTITUTE

Amy Lounsbury, Clinical Research Director, MN GASTROENTEROLOGY

Alex Markiel, Director, Clinical Operations, Head of Clinical Document Control, PHARMACYCLICS

Colleen Maude, Director, Trial Master File, MEDIMMUNE

CHAIRS

Wendy Beeby Director, Clinical Document Management and Inspection Readiness SHIRE

Grace Crawford VP Clinical Quality and Compliance MEDIMMUNE

Karen Roy Chief Strategy Officer PHLEXGLOBAL

Marie-Christine Poisson-Carvajal Head of TMF Operations PFIZER

Jamie Toth Director and Head of TMF Operations DAIICHI SANKYO

7

Conference Speakers

Lisa Mulcahy, Owner and Principal Consultant, MULCAHY CONSULTING

Curran Murphy, Director, Clinical Operations, DECIPHERA PHARMACEUTICALS

Laura Naranjo, TMF Manager, TMF Operations, DAIICHI SANKYO

Dawn M. Niccum, Director, Quality Assurance, INSEPTION GROUP

Barbara A. Novak, Senior Manager, Clinical Operations, KYOWA KIRIN PHARMACEUTICAL

Miriam Philmon, Clinical Research Manager, MYLAN

Marie-Christine Poisson-Carvajal, Head of TMF Operations, PFIZER

Minette Pugh, Advisor, Quality Systems and Compliance Management, ELI LILLY

Mark Romano, R&D Customer Success Manager, VEEVA

Karen Roy, Chief Strategy Officer, PHLEXGLOBAL

Barry Sacks, Chief Technology Officer, PHLEXGLOBAL

Bryan Souder, Director, TMF Head, MERCK

Mindy F. Taback, Clinical Trial Associate, AERIE PHARMACEUTICALS

Laura Tenbrink, TMF Manager, XCOVERY

Jamie Toth, Director and Head of TMF Operations, DAIICHI SANKYO

Stephanie Viscomi, Associate Director, Clinical Trial Office, IMMUNOGEN

Jason Weinstein, Business Lead for eTMF, REGENERON

Michele Weitz, Senior Director GCP, Compliance Operations, CLOVIS ONCOLOGY

Karen Whitson, Assistant Director, Clinical Documentation Center, ABBVIE

Alana Wriggins, Head Site Management, NA, Acquisition Integration and Clinical Records Management, ALLERGAN


Conference Speakers

SEMINARS8:30-3:30

7:30 Registration and Continental Breakfast

SEMINAR 1CREATE A PROCESS FOR TMF DOCUMENTATION

SEMINAR 2DEFINE, DEVELOP, MANAGE AND

ENHANCE YOUR TMF TEAMThe TMF management process has a lot riding on it — an inspection-ready TMF on an ongoing basis. The development of the process starts with understanding the entire suite of process documents required to ensure a complete and inspection-ready TMF. By understanding the requirements of a cross-functional and vendor-involved process, you will begin to understand how to develop the TMF management SOP so that it will cover the entire set of TMF content, involve all of the contributors to the TMF, and meet the requirements for timeliness, completeness, and quality.During this interactive seminar, attendees will:

g Review of the suite of TMF management process documents and why each one is critical to the complete process

g Discuss the roles and responsibilities of the internal and external teams, including CROs and vendors

g Explore the sponsor/CRO relationship for management of the TMF and how this definition, when captured in the process documents, leads to early success in the management of the study-specific TMF

g Develop the template of a comprehensive TMF Management SOP, capturing challenges and lessons learned to take back and apply in your own company

FacilitatorsMartina Duevel, Systems Excellence Project Leader, BAYER Lisa Mulcahy, Owner and Principal Consultant, MULCAHY CONSULTINGStephanie Viscomi, Associate Director, Clinical Trial Office, IMMUNOGEN

A highly functional TMF Operations team is critical to the successful management of the TMF. Achieving quality and inspection readiness of a TMF, and doing so efficiently, is realized by recognizing and synchronizing a myriad of factors, not the least of which are the establishments of comprehensive process definition, job roles, and responsibilities. Every trial is different, so the TMF Operations team has to be nimble to help the study team achieve the goal of an inspection-ready TMF during the conduct of the study. This seminar will look at the hard skills and the soft skills of a variety of TMF Operations representatives and the interplay of those skills to each clinical study which are all the same and different at the very same time.During this interactive workshop, attendees will:

g Clarify the scope of a TMF Operations team’s functions in well-defined rules and SOPs

g Examine the processes that impact TMF management throughout the life cycle of a clinical study

g Define your TMF Operations team, the structure, and a progression plan

g Understand the roles and responsibilities for each of the positions and how they impact the processes put in place for successful support of the TMF management process

FacilitatorsAlex Markiel, Director, Clinical Operations, Head of Clinical Document Control, PHARMACYCLICSColleen Maude, Director, Trial Master File, MEDIMMUNEBarbara A. Novak, Senior Manager, Clinical Operations, KYOWA KIRIN PHARMACEUTICAL

*Seminars include lunch and two networking breaks.

SURVEYING EACH STUDY’S NEEDS TO ENSURE SUCCESSFUL SUPPORT BY THE TMF OPERATIONS TEAMAdequate TMF management support for your trial will be a significant and persistent issue unless operations, resources, and processes are aligned. Before beginning study start-up, it’s important to take a step back to survey the landscape from a TMF-management perspective. There are so many questions to ask about study design and external vendor utilization that could affect the inspection readiness of the TMF during and after the study. The TMF Operations team needs to match skills with the study needs. Defining the TMF Operations resourcing plan is pivotal to success in addition to well-defined SOPs. Notably, this workshop will include 1) an examination of two case studies from organizations that had to review their TMF team, and 2) a minds-on group exercise.

g Survey your situation and examine each trial to determine TMF Operations-related processes and needs g Identify the pivotal and often nuanced distinctions among trials that impact successful TMF management g Assess adequacy of available resources necessary for peak operations support g Hear about real-world examples as case studies that highlight pitfalls and key elements of success g Work with a group to devise an approach from different points of view

Facilitators

Lisa Mulcahy, Owner and Principal Consultant, MULCAHY CONSULTING*Workshop includes a working diner and one networking break.

Dinner Workshop Concludes

DINNERWORKSHOP

4:00-7:30

9

Preconference Training Day Tuesday, January 22, 2019

8:00 Registration and Continental Breakfast

9:00 Summit Chairpersons’ Opening Remarks

Wendy Beeby, Director, Clinical Document Management and Inspection Readiness, SHIREGrace Crawford, VP Clinical Quality and Compliance, MEDIMMUNEMarie-Christine Poisson-Carvajal, Head of TMF Operations, PFIZERKaren Roy, Chief Strategy Officer, PHLEXGLOBAL Jamie Toth, Director and Head of TMF Operations, DAIICHI SANKYO

9:30 Use AI to Improve Efficiency in Filing, Indexing Documents, and Completeness and Accuracy of the TMF Content g Leverage document content authoring to define TMF specifications g Design smart tools to perform TMF content review g Example of a business case for next eTMF generation at Pfizer that describes how efficiency can be gained using Automation g Project the effects of AI on of workforce profile and skill sets g Convince senior management to accept the process and invest

Elisa Murphy, Senior Information Manager, PFIZERMarie-Christine Poisson-Carvajal, Head of TMF Operations, PFIZER

10:15 Apply Machine Learning and Artificial Intelligence g Hear case examples of AI application in TMF g Anticipate the skill sets that will need to be phased in/out g Learn the benefits and risks of AI and machine learning to Quality and inspection readiness g Determine where/how your particular needs should guide the level/type of AI g Discuss the impact of AI on TMF processes and what adaptations are needed g Look at the future role of AI to TMF and the industry

Barry Sacks, Chief Technology Officer, PHLEXGLOBAL

10:45 Collaborate Effectively to Transform Clinical Trials g Discuss opportunities to transform trial execution through greater TMF collaborations g Explore innovative ways to enhance collaboration by automating the exchange of TMF data between sponsors, CROs, and sites g Learn how to gain and leverage continuous visibility of clinical data exchange to improve oversight, compliance, and decision-making

Mark Romano, R&D Customer Success Manager, VEEVA

11:15 Networking Break

11:45 Case Study: Improve Quality and Execute a Culture Change Through Assessing and Addressing TMF Stakeholder Input g Understand how process changes driven by TMF stakeholder input will improve the management and quality of TMF records g Develop a culture change and implement across regions and functions g Create a governance structure with clear accountability for contributing functional areas g Implement a quality oversight process with functional accountability

Patty Fulton, Quality Consultant, TMF, ELI LILLY

12:30 Maintain an Inspection-Ready TMF With a Comprehensive and Coherent Approach by Accounting for Variables in Your Quality Management System

g Evaluate quality control processes based on viability and efficacy g Compare roles and expectations of CROs of varying sizes g Look at the impact of a variety of internal structures and operations of sponsors on QC and risk factors g Deliberate the merits, drawbacks, and resources of training and support programs g Discuss key components of a TMF Management and avoid pitfalls g Consider and surmount obstacles to CRO oversight and QC in a third-party owned system

Presentation by LMK CLINICAL RESEARCH CONSULTING


2018 Testimonial

"Preconference workshop was great. I enjoyed all the exercises and getting perspective from other TMF professionals."

—Manager, Site Operations, HEALTH DECISIONS


MAIN CONFERENCE DAY ONE Wednesday, January 23, 2019

METRICS AND TOOLS DOCUMENT MANAGEMENT CROS/SITESTRACK CHAIR

Wendy Beeby, Director, Clinical Document Management and Inspection Readiness, SHIRE

TRACK CHAIRMarie-Christine Poisson-Carvajal,

TMF Operations Lead, PFIZER

TRACK CHAIRKaren Roy, Chief Strategy Officer, PHLEXGLOBAL

2:00 Case Study: Tailor Metrics to Particular Functional Areas to Identify Issues

g Use eTMF metrics derived from functional input to increase active participation in TMF responsibilities

g Identify issues and areas for improvement in different functional areas and track progress

g Ensure that metrics from the eTMF are actionable and will be useful for regulatory reports

Jason Weinstein, Business Lead, eTMF, REGENERON

Learn About the Framework for the Destruction of Paper and Discuss Its Ramifications

g Survey the current framework g Learn what the proposed changes will entail g Hear about what the framework will be and

how it will change your work g Discuss tools that will be available g Benefit from lessons learned and address

pain points

Curran Murphy, Director, Clinical Operations, DECIPHERA PHARMACEUTICALSLiz Farrell, Senior Manager, Trial Master File, BIOGEN

Panel: Look at Proactive and Coping Measures for TMFs With Limited Resources at Start-Up

g Prepare for real challenges of document management associated with start-up and beyond

g Evaluate the processes that ensure quality and support document needs

g Discuss realistic approaches and solutions for supporting completeness and inspection readiness

g Avoid pitfalls of TMF start-up through tactical suggestions and insights from a CTA/CRA/CTM perspective

g Identify and communicate the most vital information to TMF stakeholders struggling to prioritize TMF

ModeratorAlex Markiel, Director, Clinical Operations, Head of Clinical Document Control, PHARMACYCLICSPanelistsMiriam Philmon, Clinical Research Manager, MYLAN Mindy F. Taback, Clinical Trial Associate, AERIE PHARMACEUTICALS

2:40 Transition Time2:45 Presentation by

Kathie Clark, Vice President, Product Management, WINGSPAN TECHNOLOGIES, AN IQVIA COMPANY

Case Study: Use AI to Manage Documents

g Hear about the exploratory, planning, and pilot process

g Explore the limits and the possibilities of AI g Look at the roles various functions played in

the concerted effort to implement g Avoid pitfalls of AI by hearing lessons learned g Discuss how AI changes the QC processes

Mary Emanoil, Senior Director, Content Management and Authoring, PFIZER

Meet ICH E6(R2) Expectations of Regulators Through CRO Oversight and Collaboration

g Look at what types of document are required by ICH E6 (R2)

g Examine the risk-based approach to CRO/vendor management

g Work with CROs to implement and make sure sites are on board

g Look at metrics that ensure ongoing trial inspection readiness

g Conduct oversight of CRO

Ann McCabe, Director, Process Excellence and Risk Management Clinical Development Operations, DAIICHI SANKYO


2018 Testimonial

“It is great to hear from others that do what I do and understand my concerns and offer solutions. It really helps my confidence that I am doing what is best regarding the TMFs I manage.”—Clinical Document Management Specialist, CR BARD

11


METRICS AND TOOLS DOCUMENT MANAGEMENT CROS/SITES3:30 Shift the Paradigm to Measure What

Matters This minds-on session will challenge participants’ conceptions of their measurement practices. Case examples will be discussed to reveal alternatives to evaluate and monitor trials.

g Invoke change by challenging your metrics and how you use them

g Assess on the accuracy and efficacy of your metrics

g Question what you are measuring and what can be measured

g Deliberate the variety of possible interpretations of the same measure

g Find out if your measure is telling you what you think it is

Liz Farrell, Senior Manager, Trial Master File, BIOGEN

Ensure Seamless Audits by Making the Most of What Your eTMF Offers

g Make an eTMF your primary tool for an efficient, successful audit

g Discover your eTMF’s capabilities for options to best analyze the health of your TMF

g Understand the importance of effective metadata; how it can affect audits and all users of the system

g Create a proactive approach and confident outlook on audit readiness with your QC Process

g Hear best practices on metadata clean-up for reliability

g Use your eTMF to its full potential for efficient retrieval of inspection documents

Evelin Baez, Clinical Document Management Specialist, BECTON DICKINSON

Enhance Your CRO/Sponsor Relationship While Maintaining a Constant State of Inspection Readiness

g Know and convey the “Ins and Outs” of the DIA filing matrix

g Deal with pushback from CROs by sharing the onus of QC and inspection readiness

g Improve collaboration by changing your mindset and language ((i.e., use “input” or “feedback” as opposed to “pushback”)

g Discuss best practices working with multiple CROs with far-ranging cultures, needs, resources and expectations

g Establish expectations and provide support

Laura Tenbrink, TMF Manager, XCOVERY

4:10 Transition Time 4:15 Case Study: Learn About AbbVie’s Risk-

Based QC Process g Achieve risk-based QC for completion,

timeliness, and quality g Develop metrics with intent to identify the

most relevant risk factors g Account for heightened risks resulting from

new and pending regulations g Adapt governance processes to deliberate

over causes and necessary modifications g Identify studies that may need more support

Nela Hayes, Senior Manager, Clinical Documentation, ABBVIEKaren Whitson, Assistant Director, Clinical Documentation Center, ABBVIE

Case Study: Plan and Execute Migrations of Disparate Types of TMFs

g Anticipate and avoid inspection readiness pitfalls

g Determine what QC measures should be taken before and after migration

g Hear about specific challenges and lessons learned in various scenarios, including:

• CRO Paper TMF to Sponsor eTMF• CRO eTMF to Sponsor eTMF• Mid-Study Paper TMF to Sponsor eTMF• Transition from Acquisition TMF to

Sponsor eTMF

Victoria Ho, Director Clinical Operations, GILEAD

Case Study: Provide Inspection Support With Comprehensive Guidance, Instruction, Training and Support to CROs Using Their Own eTMF System

g Compare and contrast inherent challenges of maintaining an exchange-ready eTMF when using large vs. small CROs

g Discuss advantages and disadvantages of inspection preparation using a CRO’s eTMF

g Hear how groups and committees conduct oversight at Merck

g Overcome transparency issues and through good governance and Quality Management Systems

Karen Freid, Essential Document Specialist, MERCK

5:00 Networking Reception6:00 Day One Concludes

2018 Testimonials

“I think two things you nailed that other conferences have issues with is the ratio of presentations to vendor networking, and allowing for time to move between sessions”

—Process Improvement Manager, COOK MEDICAL

“The event was very informative and will greatly impact current TMF processes in my role.” —Clinical Research Support Specialist, NUVENTRA PHARMA SCIENCES



INSPECTIONS BUSINESS/INTEGRATION eTMF/TECHNOLOGY 8:15 Continental Breakfast Begins

9:00 Track Chair Recap Day One

Grace Crawford, VP Clinical Quality and Compliance, MEDIMMUNE

Track Chair Recap Day One

Karen Roy, Chief Strategy Officer, PHLEXGLOBAL

Track Chair Recap Day One


9:10 Panel: Prepare for a TMF Inspection With a Quality Management System

g Manifest prioritization drivers in your metrics to avoid critical findings

g Hear examples of mock audits improving inspection readiness by informing process modifications

g Hear how various constituencies are involved in inspections

g Conduct audits in accordance with inspection trends and pending changes

g Survey common pitfalls for inspections and discuss how they may be avoided

Moderator Bryan Souder, Director, TMF Head, MERCK Panelists Dawn M. Niccum, Director, Quality Assurance, INSEPTION GROUP

Stephanie Viscomi, Associate Director, Clinical Trial Office, IMMUNOGEN

Case Study: Steps to Build a Robust Function QC Process to Ensure IR

g Look at examples of tailored quality metrics and tools for particular functional areas

g Learn how Daiichi Sankyo on-boarded leaders and staff in functional areas

g Discuss examples of ways that collaboration is facilitated throughout QC

g Hear lessons learned for planning, piloting and implementing

g Improve IR by customizing steps to address nuanced needs of various functions

Christina Allen, Senior TMF Specialist, TMF Operations, DAIICHI SANKYO

Laura Naranjo, TMF Manager, TMF Operations, DAIICHI SANKYO

Leverage Your eTMF Technology to Engage Stakeholders Through a Business – IT Approach

g Create a cohesive team of clinical trialmanagement TMF SME’s throughout various functions

g Customize upgrades to your eTMF systems based on user need

g Keep people focused on meaningful tasks by leveraging new functionalities

g Develop synergy between the business and IT

Rebecca Halbur, Senior Manager, TMF Systems, BIOGEN

9:55 Transition Time10:00 Contend With Pain Points of Acquisition to

Passing Inspection g Recognize the impact of merging TMFs on

compliance g Examine impediments to inspection readiness

resulting from M&A g Identify priority areas to focus on based on

inspection trends g Sort out first steps and steps most often

neglected in the planning process g Know what to look for in audits to identify

issues of document management g Establish responsibilities and provide

essential training for internal functions, CROs and sites

Alana Wriggins, Head Site Management, North America, Acquisition Integration and Clinical Records Management, ALLERGAN

Case Study: Business Embedment: Influence Corporate Strategy With C-Level Buy-In

g Hear how MedImmune’s TMF department leads the initiative to develop corporate management strategy

g Examine history of AstraZeneca that established the need for change in the framework

g Explore operating model TMF put forth to corporate for that garnered their support

g Get license from corporate to infiltrate all levels of organization

g Determine corporate level goals based on corporate level needs

g Learn how without additional resources departments compensated

Colleen Maude, Director, Trial Master File, MEDIMMUNE

Improve Interoperability Through Automation

g Learn the implications of the TMF Exchange Mechanism for TMF automation

g Outline the benefits and explore the limits of automation to improving TMF systems and processes

g Review functional systems that draw from or impact eTMF content

g Expedite and augment interoperability by using AI to extract artifacts, emails, and data

Martina Duevel, Systems Excellence Project Leader, BAYER


2018 Testimonials

“Good way to ask some tough questions. I thought the format was very creative.” —Senior CTA Clinical Systems, ALKERMES

“Great case studies, very practical and applicable.”—TMF Specialist, BIOMARIN

13

MAIN CONFERENCE DAY TWO Thursday, January 24, 2019

INSPECTIONS BUSINESS/INTEGRATION eTMF/TECHNOLOGY11:15 Case Study: E Pluribus Unum, Achieve

SSOT g Understand the benefits of a “Single Source of

Truth” TMF to Avoiding Findings g Apply takeaway messages from multiple

sponsor inspections by FDA, EMA, and MHRA g Consider lessons learned from the

harmonization and merging of Sponsor/CRO hybrid paper and electronic TMFs into a single, Sponsor eTMF

g Discuss implications of SSOT to how you work with CROs

g Address challenges SSOT poses for data integrity

Michele Weitz, eSenior Director GCP, Compliance Operations, CLOVIS ONCOLOGY

Case Study: Align Technologies and Streamline Processes to Support the Ability of Cross-Functions to Work With Vendors

g Work internally with IT and other partners to road map and implement your reform

g Marry the world of business requirements with the world of regulations to ensure ICH and GxP compliance

g Improve efficiency and improve by streamline process internally

g Incorporate big data mapping and share data across functions to maximize partnerships

g Enact thoughtful access management and plan training accordingly

Jennifer Arters, eClinical Manager eTMF and Collaboration, CSL BEHRING

Born to Be Contemporaneous: Road Mapping Your eTMF to Evolve Technology in Accord With Changing Passenger Need, Rules of the Road, and Road Conditions

g Establish a system to routinely update and refine your systems

g Determine business impact and resources by engaging engage multiple functions

g Leverage end-user experience and input to streamline processes

g Take account of the ramifications of proposed change to training

g Enhance road map because of regulatory mandates or audit findings

g Compare enhancements of various prioritization levels and classifications

g Estimate the resources that will be necessary augment your system

g Look at a case example of Daiichi Sankyo’s change control board’s role


12:00 Transition Time12:10 Work in Concert With Your CRO Partners

to Prepare for Inspection in Accordance With Trends

g Explore CRO engagement and preparation strategies to ally with CROs to identify and avoid errors

g Discuss inspection trends and their implications for inspection preparation

g Utilize audits and mock inspections to ensure you are inspection ready

g Convey clear expectations to stakeholders for inspection readiness

g Address particular challenges related to data integrity and external data sources

Elias Dorfman, Clinical Quality Manager, MERCK

Case Study: Hear a Journey to TMF Compliance — A CT Supply Chain Functional Perspective Through Three Lenses (Quality, Business, and Cross-Functional Collaboration)

g Discuss intersection of GCP, GDP, and GMP and comparing requirements and document types while linking back to DIA Reference Model

g Drive cultural change within the function and develop new business processes using a risk-based and resource-aware approach

g Partner with central TMF group and other supporting functions to ensure business process alignment while fostering understanding of unique challenges of clinical supply group

g Explore next steps and continuous process improvements

Sonja Davis, QA Consultant, QA-Product Research and Development, ELI LILLY Thomas Miller, Manager, Clinical Supplies Planning and Execution, ELI LILLY Minette Pugh, Advisor, Quality Systems and Compliance Management, ELI LILLY

Panel: Explore the Impact, Prerequisites and Application of Emerging Technologies

g Learn how different companies have applied automation, AI and machine learning

g Outline capabilities, resources and other factors that must be in place

g Look at the limiting factors and challenges of technology

g Explore the limitations and possibilities that technological advances afford and will afford

g Utilize tips, techniques and tools to maximize benefit and minimize drawbacks

Andy Chu, Director, Regulatory Affairs — Regulatory Systems Strategy, BIOGEN

2018 Testimonial

“Greatest benefit was the wealth of information on implementation and maintenance of the TMF, the exchange of ideas and resources in the networking breaks as well as the tips provided in the speakers.” —Clinical Trial Administration, CHIESI




1:45 PANEL: The Future of eTMF: What Are the Key Change Enablers? g Interoperability — essential requirements for machine-to-machine exchange of TMF content g Traceability and data integrity (need for a redefinition of audit trail) g Inspection readiness and wider scope — the challenge of inspection of multiple electronic systems g Connecting the dots, challenges in the presentation of TMF information and ability to tell an accurate story g To TMF or not to TMF — need for more specific guidance from the regulators; potential ratification of the TMF RM by ICH?

ModeratorPaul Fenton, President and CEO, MONTRIUM

2:30 PANEL: Be Inspection-Ready by Effecting a Unified TMF by Collaborating With CROs g Hear a CRO’s perspective of sponsor-developed metrics and KPIs g Improve internal and external processes through training and support g Discuss how expectations of a sponsor can be effectively conveyed or adapted to improve symbiosis g Get insights into how your KPIs can better account for CROs own assessment systems g Hear case examples of improvements made through sound governance

3:15 PANEL: Learn From Sites to Standardize Procedures, Provide Support and Develop Trainings g Provide empathetic/user-driven operations and protocols for site adherence g Hone the collection and management of Electronic Investigator Site Files (eISF) g Hear tactics for universal practices for the labeling and filing of documents g Prepare the site/sponsor teams along with the site/CRA/sponsor tools g Hear tactics and tips sites would recommend based on their stressors

ModeratorAlana Wriggins, Head Site Management, North America, Acquisition Integration and Clinical Records Management, ALLERGANPanelistsAmy Gunnett, Certified Clinical Research Coordinator, UNIVERSITY OF FLORIDA Aryn Knight, Clinical Research Oversight Specialist; Assistant Administrative Director — Center for Clinical Research, TEXAS HEART INSTITUTEAmy Lounsbury, Clinical Research Director, MN GASTROENTEROLOGY

4:15 Conference Chair’s Closing Remarks

5:00 Conference Concludes

2018 Testimonials

“Great info, lots of opportunity for networking, idea sharing, excellent management.”—Senior TMF Project Manager, RHO

“As a TMF associate, I enjoy attending this conference to learn about industry trends and seeing how our vertex standards compare across other companies.” —TMF Associate, VERTEX PHARMACEUTICALS

“This was my first summit. Not only did it meet my development goals, but also business related goals. …. I didn’t expect to take away as many nuggets from both presenters and other attendees.” —Supervisor, CTAs | eTMF SME, SEATTLE GENETICS

“Enjoyed hearing case studies and implementing an eTMF and leveraging metrics.” —Records Analyst, ASTELLAS

“Greatest benefit was hearing all the different techniques everyone has to bring TMF together.” —Clinical Trial Administration, MITSUBISHI TANABA PHARMA

15


TERMS AND CONDITIONS: By registering for an ExL Events (“ExL”) event, you agree to the following set of terms and conditions listed below:

REGISTRATION FEE: The fee includes the conference‚ all program materials‚ and desig-nated continental breakfasts‚ lunches and refreshments.

PAYMENT: Make checks payable to ExL Events and write 794519 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full by the conference date. Any discount applied cannot be combined with any other offer and must be paid in full at the time of order. Parties must be employed by the same organization and register simultaneously to realize group discount pricing options.

**Please Note: There will be an administrative charge of $300 to substitute, exchange and/or replace attendance badges with a colleague within five business days of any ExL conference.**

CANCELLATION AND REFUND POLICY: If you cancel your registration for an upcoming ExL event, the following policies apply, derived from the Start Date of the event:• Four weeks or more: A full refund (minus a $295 processing fee) or a voucher to another ExL event valid for 12 months from the voucher issue date.• Less than four weeks: A voucher to another ExL event valid for 12 months from thevoucher issue date.• Five days or less: A voucher (minus a $395 processing and documentation fee) to another ExL event valid for 12 months from the voucher issue date.

changes cannot be made. In the event of cancellation on the attendees’ behalf, the credit voucher will no longer be valid.

ExL Events does not and is not obligated to provide a credit voucher to registered attend-ee(s) who do not attend the event they registered for unless written notice of intent to cancel is received and confirmed prior to the commencement of the event.

SUBSTITUTION CHARGES: There will be an administrative charge of $300 to substitute, exchange and/or replace attendee badges with a colleague occurring within five business days of the conference.

ExL Events reserves the right to cancel any conference it deems necessary and will not be responsible for airfare‚ hotel or any other expenses incurred by registrants.

ExL Events’ liability is limited to the conference registration fee in the event of a cancella-tion and does not include changes in program date‚ content‚ speakers and/or venue.

*The opinions of ExL’s conference speakers do not necessarily reflect those of the compa-nies they represent, nor ExL Events.

Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, significant effort to find a suitable replacement will be made. The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL’s designated speakers and is designed for informational purposes for its attendees. It is NOT INTENDED for purposes of copywriting or redistribu-tion to other outlets without the express written permission of ExL’s designated speaking parties. Neither ExL nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IM-PLIED, AS TO THE ACCURACY OF ANY CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties.

How to Register Click Here or:

Early Bird Pricing Register by November 30, 2018

Conference Only: $1,995

All-Access Pass: $2,795

Registration Fees for Attending ExL’s 8th Trial Master File Summit

Standard Rate Pricing



Onsite Pricing



GROUP DISCOUNT PROGRAMOffers may not be combined. Early Bird rates do not apply. To find out more on how you can take advantage of these group discounts, please call 866-207-6528.

PER PERSON WHEN REGISTERING FOUR For every three simultaneous registrations from your company, you will re-ceive a fourth complimentary registration to the program (must register four at one time). This is a savings of 25% per person.

PER PERSON WHEN REGISTERING THREE Can only send three? You can still save 15% off of every registration.

SAVE 25%

SAVE 15%

A La Carte Add-On Pricing

Seminar 1: $695Seminar 2: $695

Dinner Workshop: $395

*All Access Pass includes one seminar and the dinner workshopClinical sites, academics and nonprofits will receive a 30% discount off the standard pricing for the conference.


201 871 0474 @ [email protected] 663 7224

PMA Conference ManagementPO Box 2303Falls Church VA 22042

http://events.constantcontact.com/register/event?llr=7esc4ioab&oeidk=a07efpv76m6ddacd380